Home LiteratureArticle Details
PMID: 17721441 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

New androgen receptor genomic targets show an interaction with the ETS1 transcription factor.

EMBO reports ·Vol. 8 ·No. 9 ·2007-09-00 ·Pages 871-8

Massie CE, Adryan B, Barbosa-Morais NL, Lynch AG, Tran MG, Neal DE, Mills IG

Abstract

The androgen receptor (AR) initiates important developmental and oncogenic transcriptional pathways. The AR is known to bind as a homodimer to 15-base pair bipartite palindromic androgen-response elements; however, few direct AR gene targets are known. To identify AR promoter targets, we used chromatin immunoprecipitation with on-chip detection of genomic fragments. We identified 1,532 potential AR-binding sites, including previously known AR gene targets. Many of the new AR target genes show altered expression in prostate cancer. Analysis of sequences underlying AR-binding sites showed that more than 50% of AR-binding sites did not contain the established 15 bp AR-binding element. Unbiased sequence analysis showed 6-bp motifs, which were significantly enriched and were bound directly by the AR in vitro. Binding sequences for the avian erythroblastosis virus E26 homologue (ETS) transcription factor family were also highly enriched, and we uncovered an interaction between the AR and ETS1 at a subset of AR promoter targets.

MeSH Terms
Base Sequence Binding Sites Cell Line, Tumor Chromatin Immunoprecipitation Genome, Human/genetics Humans Molecular Sequence Data Promoter Regions, Genetic/genetics Protein Binding Proto-Oncogene Protein c-ets-1/metabolism Receptors, Androgen/metabolism Sequence Analysis, DNA
Chemicals
AR protein, human ETS1 protein, human Proto-Oncogene Protein c-ets-1 Receptors, Androgen
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Massie Charles E
Uro-Oncology Research Group, Department of Oncology, University of Cambridge, Cancer Research UK Cambridge, Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. charlie.massie@cancer.org.uk
Adryan Boris
Barbosa-Morais Nuno L
Lynch Andy G
Tran Maxine G
Neal David E
Mills Ian G
References (24)
24 references, click to expand
  1. OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways.
    Cell. 2000 Jan 21;100(2):229-40 PMID: 10660046
  2. Identification of androgen-regulated genes in the prostate cancer cell line LNCaP by serial analysis of gene expression and proteomic analysis.
    Proteomics. 2001 Oct;1(10):1327-38 PMID: 11721644
  3. ETS-1 transcription factor binds cooperatively to the palindromic head to head ETS-binding sites of the stromelysin-1 promoter by counteracting autoinhibition.
    J Biol Chem. 2002 Aug 16;277(33):29386-98 PMID: 12034715
  4. Selective DNA recognition by the androgen receptor as a mechanism for hormone-specific regulation of gene expression.
    Mol Genet Metab. 2003 Mar;78(3):175-85 PMID: 12649062
  5. E2F6 negatively regulates BRCA1 in human cancer cells without methylation of histone H3 on lysine 9.
    J Biol Chem. 2003 Oct 24;278(43):42466-76 PMID: 12909625
  6. Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance.
    Am J Pathol. 2004 Jan;164(1):217-27 PMID: 14695335
  7. Molecular determinants of resistance to antiandrogen therapy.
    Nat Med. 2004 Jan;10(1):33-9 PMID: 14702632
  8. Identification and validation of novel androgen-regulated genes in prostate cancer.
    Endocrinology. 2004 Aug;145(8):3913-24 PMID: 15131019
  9. Androgen receptors in endocrine-therapy-resistant human prostate cancer.
    Int J Cancer. 1991 May 10;48(2):189-93 PMID: 1708363
  10. Tissue-specific and hormonal regulation of human prostate-specific glandular kallikrein.
    Biochemistry. 1992 Jan 28;31(3):818-24 PMID: 1370633
  11. A consensus DNA-binding site for the androgen receptor.
    Mol Endocrinol. 1992 Dec;6(12):2229-35 PMID: 1491700
  12. Androgen induction of a human prostate-specific kallikrein, hKLK2: characterization of an androgen response element in the 5' promoter region of the gene.
    Biochemistry. 1993 Jun 29;32(25):6459-64 PMID: 7686046
  13. Bicalutamide for advanced prostate cancer: the natural versus treated history of disease.
    J Clin Oncol. 1997 Aug;15(8):2928-38 PMID: 9256137
  14. Overexpression of Ets-1 proto-oncogene in latent and clinical prostatic carcinomas.
    Histopathology. 2005 Feb;46(2):202-8 PMID: 15693893
  15. Cancer incidence and mortality in Europe, 2004.
    Ann Oncol. 2005 Mar;16(3):481-8 PMID: 15718248
  16. NestedMICA: sensitive inference of over-represented motifs in nucleic acid sequence.
    Nucleic Acids Res. 2005;33(5):1445-53 PMID: 15760844
  17. MatInspector and beyond: promoter analysis based on transcription factor binding sites.
    Bioinformatics. 2005 Jul 1;21(13):2933-42 PMID: 15860560
  18. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1.
    Cell. 2005 Jul 15;122(1):33-43 PMID: 16009131
  19. Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells.
    J Steroid Biochem Mol Biol. 2005 Aug;96(3-4):251-8 PMID: 15982869
  20. From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response.
    Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11651-6 PMID: 16087863
  21. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.
    Science. 2005 Oct 28;310(5748):644-8 PMID: 16254181
  22. Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression.
    Cancer Cell. 2005 Nov;8(5):393-406 PMID: 16286247
  23. Genomic actions of the androgen receptor are required for normal male sexual differentiation in a mouse model.
    J Mol Endocrinol. 2005 Dec;35(3):547-55 PMID: 16326839
  24. Integrative molecular concept modeling of prostate cancer progression.
    Nat Genet. 2007 Jan;39(1):41-51 PMID: 17173048
Article Info
Journal
EMBO reports
Abbr.
EMBO Rep
ISSN
1469-221X
Published
2007-09-00
Epub
2007-00-17
Pages
871-8
Language
English
Region
England
NLM ID
100963049
PMCID
PMC1950328
Subset
IM
Grants
Medical Research Council · G0500966 · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com